🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💔😞 RIP, my friend Felix Feng Please consider donating to the American Cancer Society ASTRO Felix Feng MD Clinician Scientist Grant Award. Let his incredible legacy live on. donate.cancer.org/g/tjjfqwdnrxrl…

Sadden to hear about Felix Feng passing today. A true legend in GU. My deepest condolences to Mary Feng and the family. Felix will be deeply missed by our GU community as an incredible scientist and an amazing human being who was always very kind and always smiling.

The last time Felix stood on our stage, after a beautiful talk by Misha Beltran & intro by @AminaZoubeidi 💔💔💔 vimeo.com/1037583309/b7d…

The lights in our lab didn’t work yesterday morning. In a way it was a sign that we lost the biggest light in our lives. Felix Feng was my mentor in work and in life, and I am a better scientist and person for having been trained by him. His legacy will live on in all of us 💙

Olaparib effective in BRCA2-altered biochemical recurrence post-prostatectomy in phase 2 study. Cathy Handy Marshall, MD MPH Johns Hopkins Medicine joins Andrea Miyahira Prostate Cancer Foundation highlighting a study on olaparib for high-risk biochemically recurrent prostate cancer post-prostatectomy, showing PSA-50

Polyaneuploid cancer cells drive metastasis and resist treatments in #ProstateCancer. Sarah R. Amend, Ph.D. Johns Hopkins Medicine joins Andrea Miyahira Prostate Cancer Foundation to discuss her research on polyaneuploid cancer cells (PACCs) and their role in metastasis, published in Molecular Cancer Research. #WatchNow on

🚨 Improving clinical trial access & diversity 🚨 Andrea Miyahira Prostate Cancer Foundation chats with Dr. Hala Borno UCSF Helen Diller Family Comprehensive Cancer Ctr about Trial Library, a platform connecting 1,500+ providers & 300 clinics to clinical trials. The technology-enabled service connects community providers with

Elevated CBP/p300 expression linked to poor outcomes in advanced #ProstateCancer. Ayesha Shafi, PhD Center for Prostate Disease Research joins Andrea Miyahira Prostate Cancer Foundation to discuss AR coactivators CBP/p300 in prostate cancer and research revealing that CBP/p300 expression increases as prostate cancer

In memory of Dr. Felix Feng. Thank you European Urology for honoring our beloved colleague and friend, gone too soon. We miss you Felix Mary Feng Nancy Lin, MD PCF Science sciencedirect.com/science/articl…

Prayers and strength tonight to all our friends and colleagues in Los Angeles affected by these devastating fires. LA is in a state of emergency and over 30,000 have been ordered to evacuate. #lafires

Study reveals how #ProstateCancer alters bone structure, increasing fracture risk. Felipe Eltit Guersetti Vancouver Prostate Centre joins Andrea Miyahira Prostate Cancer Foundation to discuss his research on prostate cancer bone metastases, focusing on their structural characteristics and impact on bone

Concerning prevalence of misinformation in cancer-related articles shared on social media. Harmful articles had significantly more viewer engagement ☠️ -Skyler Johnson, MD #WorldCancerDay event Dana-Farber Harvard T.H. Chan School of Public Health

MYC’s role in #ProstateCancer immune suppression and progression. Mindy Kim Graham NM Urology joins Andrea Miyahira Prostate Cancer Foundation to discuss her research, which reveals how MYC activation drives consistent changes in the tumor microenvironment across both human and mouse models of

The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. We urge Congress to restore stability to NIH: brnw.ch/21wQMO3

ANNOUNCEMENT: RFA for 2025 Prostate Cancer Foundation Young Investigator Award Applications, to support innovative & highly promising early career #ProstateCancer researchers. DEADLINE: March 10, 2025 Apply at: pcf.smartsimple.com View the RFA here: res.cloudinary.com/pcf/images/v17…

Closing an incredible era leading American Cancer Society + American Cancer Society Cancer Action Network. So proud of what we accomplished in the last 4 yrs and could not ask for a better team. TY Team ACS for this farewell video—I will treasure it! 💙

ANNOUNCEMENT: RFA for 2025 Prostate Cancer Foundation team science Challenge Award Applications, to support investigations of metastatic, lethal #ProstateCancer in 6 specified topic areas. DEADLINE: May 5, 2025 Apply at: pcf.smartsimple.com View the RFA: res.cloudinary.com/pcf/images/v17…

Join us in welcoming Karen Knudsen, MBA PhD as PICI's Chief Executive Officer! A visionary in oncology, healthcare delivery & nonprofit strategy, Dr. Knudsen embodies the values that define PICI: scientific rigor, bold thinking & a commitment to transformative patient impact. (1/3)

Proud of my growing team at UPenn — united by one mission: to cure prostate cancer using novel, engineered CAR T cells. Grateful to my mentor Dr. Carl June Carl June for trusting me to lead a team of brilliant, motivated scientists! Penn Medicine Prostate Cancer Foundation

ANNOUNCEMENT: RFA for 2025 Prostate Cancer Foundation TACTICAL Award Letters Of Intent, for multi-institutional research projects to target lethal #ProstateCancer, in 6 specified topic areas. LOI DEADLINE: May 19, 2025 View RFA: res.cloudinary.com/pcf/images/v17… View LOI form: res.cloudinary.com/pcf/images/v17…